GETI.B

198.6

+2%↑

ATT

102.6

+1.38%↑

AMBEA

130.8

+2.19%↑

ARJOB

26.1

+0.08%↑

MSON.B

11.35

+5.09%↑

GETI.B

198.6

+2%↑

ATT

102.6

+1.38%↑

AMBEA

130.8

+2.19%↑

ARJOB

26.1

+0.08%↑

MSON.B

11.35

+5.09%↑

GETI.B

198.6

+2%↑

ATT

102.6

+1.38%↑

AMBEA

130.8

+2.19%↑

ARJOB

26.1

+0.08%↑

MSON.B

11.35

+5.09%↑

GETI.B

198.6

+2%↑

ATT

102.6

+1.38%↑

AMBEA

130.8

+2.19%↑

ARJOB

26.1

+0.08%↑

MSON.B

11.35

+5.09%↑

GETI.B

198.6

+2%↑

ATT

102.6

+1.38%↑

AMBEA

130.8

+2.19%↑

ARJOB

26.1

+0.08%↑

MSON.B

11.35

+5.09%↑

Inicio・Lista de Acciones・Orexo AB

O
Orexo AB

Cerrado

25.85 1.37

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

25.1

Máximo

26.25

Métricas clave
By Trading Economics
Ingresos	-68M -116M
Ventas	-115M 3.3M
BPA	20.884
Margen de beneficios	-3,503.03
Empleados	72
EBITDA	-262M -272M

Dividendos
By Dow Jones
Próximas Ganancias	28 abr 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-97M 937M
Apertura anterior	24.48
Cierre anterior	25.85

Orexo AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 mar 2026, 18:43 UTC

Noticias de Eventos Importantes

Fed's Kashkari Says Too Soon To Know Inflation Impact From Middle East Conflict

3 mar 2026, 17:33 UTC

Adquisiciones, fusiones, absorciones

Ziff Davis to Sell Connectivity Division to Accenture for $1.2 Billion -- Update

3 mar 2026, 23:45 UTC

Charlas de Mercado

Nikkei May Fall on Continued Concerns About Energy Costs -- Market Talk

3 mar 2026, 23:44 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Rises on Possible Dip-Buying Amid Ongoing Middle East Conflict -- Market Talk

3 mar 2026, 23:25 UTC

Charlas de Mercado

Bannerman Energy Likely to Raise Less Equity for Uranium Projects -- Market Talk

3 mar 2026, 23:25 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

3 mar 2026, 22:38 UTC

Noticias de Eventos Importantes

Iran Conflict Pushes Europe Toward Fresh Energy Crisis -- WSJ

3 mar 2026, 22:16 UTC

Ganancias

Berkshire Provides Scant Fourth-Quarter Financials. Investors Need to Do Their Own Calculations. -- Barrons.com

3 mar 2026, 22:09 UTC

Ganancias

Century Aluminum Changed Historical Method of Proportionately Consolidating Jamalco Production Assets to a Full Consolidation

3 mar 2026, 22:06 UTC

Ganancias

Century Aluminum: Accounting Change for 2023 and 2024 Doesn't Impact Net Income Attributable to Century Stockholders

3 mar 2026, 22:05 UTC

Ganancias

Century Aluminum Initially Concluded That an Accounting Change Was Immaterial, SEC Staff Disagreed With Company's Materiality Conclusion

3 mar 2026, 22:03 UTC

Ganancias

Century Aluminum to Restate Certain Results in Connection Wtih Accounting Change for Jamalco

3 mar 2026, 21:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Tech, Media & Telecom Roundup: Market Talk

3 mar 2026, 21:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

3 mar 2026, 21:45 UTC

Noticias de Eventos Importantes

The Iran War Puts the Fed's Rate-Cut Timeline in Doubt -- Barrons.com

3 mar 2026, 21:37 UTC

Ganancias

EVgo Stock Rises as Earnings Defy EV Slump. The Rest of 2026 Doesn't Look So Rosy. -- Barrons.com

3 mar 2026, 21:26 UTC

Noticias de Eventos Importantes

Freeport McMoRan Stock Slides as the Mideast Conflict Hits Commodities -- Barrons.com

3 mar 2026, 20:31 UTC

Charlas de Mercado

Noticias de Eventos Importantes

U.S. Natural Gas Gains on Middle East Turmoil, Weather Outlook -- Market Talk

3 mar 2026, 20:04 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Pull Back as Trump Offers Shipping Protection -- Market Talk

3 mar 2026, 19:17 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold and Silver Drop as Energy Surges -- Market Talk

3 mar 2026, 18:43 UTC

Ganancias

Berkshire CEO Abel Is Fond of Financial Metric Similar to One Criticized by Buffett -- Barrons.com

3 mar 2026, 18:29 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Energy Roundup: Market Talk

3 mar 2026, 18:29 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Norsk Hydro Announces Stoppage of Qatar Aluminum Smelter -- Market Talk

3 mar 2026, 18:22 UTC

Noticias de Eventos Importantes

Fed's Kashkari on March Projections: Had a Lot of Confidence Up Until a Few Days Ago

3 mar 2026, 18:22 UTC

Noticias de Eventos Importantes

Fed's Kashkari: Too Soon to Know Impact Iran Conflict Will Have on Inflation

3 mar 2026, 18:17 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Strait of Hormuz Standstill Keeps Bid in Oil Futures -- Market Talk

3 mar 2026, 18:14 UTC

Ganancias

How Long Can Anthropic Play Defense? -- WSJ

3 mar 2026, 17:41 UTC

Noticias de Eventos Importantes

Exxon Is Down Since the Iran Conflict. These Energy Stocks Are Bigger Winners. -- Barrons.com

3 mar 2026, 17:36 UTC

Noticias de Eventos Importantes

Iran Conflict is Starting to Boost Gasoline Prices -- Update

3 mar 2026, 17:28 UTC

Adquisiciones, fusiones, absorciones

Tinicum, Blackstone to Make Decision on Offer By End of Day March 31

Comparación entre iguales

Cambio de precio

Orexo AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.